Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application of Ketamine Combined With Dexmedetomidine Sedation in Magnetic Resonance Imaging of Children With Autism and Autism Spectrum Disorder:a-Randomized Controlled Trial

NCT06633315 is registered in ClinicalTrials.gov with Maternal and Child Health Hospital of Hubei Province as lead sponsor.

NCT NCT06633315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06633315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application of Ketamine Combined With Dexmedetomidine Sedation in Magnetic Resonance Imaging of Children With Autism and Autism Spectrum Disorder:a-Randomized Controlled Trial
Lead sponsor
Maternal and Child Health Hospital of Hubei Province
Phase
Phase 2
Overall status
Completed
Start date
December 1, 2022
Completion date
September 1, 2024
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder, dexmedetomidine, esketamine, sedation